Hill-Rom Holdings Inc (HRC) Lifted to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Hill-Rom Holdings Inc (NYSE:HRC) from a hold rating to a buy rating in a report issued on Friday. The brokerage currently has $90.00 price target on the medical technology company’s stock.

According to Zacks, “Hill-Rom saw a solid year-over-year increase in revenues on strong international growth. Hill-Rom currently aims to gain traction in the untapped international market on successful execution. The company is focusing on product innovation through research and development. Also, its launches slated for the fourth quarter are pumping up investors’ confidence. With regard to this, the commercial launch of its Centrella Med-Surg platform is worth a mention. However, over the last six months, Hill-Rom has been underperforming the broader industry. Moreover, it exited the last reported quarter on a mixed note with earnings ahead of estimates but revenues missing the same. Also, decrease in Patient Support Systems revenues was disappointing. Moreover, a decline in reported gross margin was dampening. Also, lowered full year guidance suggests dull prospects ahead.”

Several other equities research analysts have also issued reports on HRC. BidaskClub lowered shares of Hill-Rom Holdings from a buy rating to a hold rating in a research report on Monday, July 31st. KeyCorp reiterated a buy rating and set a $82.00 target price on shares of Hill-Rom Holdings in a research report on Tuesday, October 17th. Cantor Fitzgerald assumed coverage on shares of Hill-Rom Holdings in a research report on Thursday, June 29th. They set a neutral rating and a $86.00 target price for the company. Stifel Nicolaus reiterated a buy rating and set a $84.00 target price on shares of Hill-Rom Holdings in a research report on Sunday, July 30th. Finally, Needham & Company LLC assumed coverage on shares of Hill-Rom Holdings in a research report on Thursday, June 29th. They set a buy rating and a $95.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of $87.29.

Shares of Hill-Rom Holdings (NYSE HRC) opened at 80.52 on Friday. The stock’s 50 day moving average is $76.89 and its 200-day moving average is $76.82. The company has a market cap of $5.30 billion, a P/E ratio of 46.92 and a beta of 1.19. Hill-Rom Holdings has a one year low of $50.50 and a one year high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The company had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. During the same period last year, the business earned $0.81 earnings per share. Hill-Rom Holdings’s revenue was up 5.1% compared to the same quarter last year. Equities research analysts forecast that Hill-Rom Holdings will post $3.82 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Hill-Rom Holdings Inc (HRC) Lifted to “Buy” at Zacks Investment Research” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.com-unik.info/2017/10/30/hill-rom-holdings-inc-hrc-lifted-to-buy-at-zacks-investment-research.html.

In related news, SVP Andreas G. Frank sold 3,940 shares of Hill-Rom Holdings stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the transaction, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Andreas G. Frank sold 6,870 shares of Hill-Rom Holdings stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at $1,293,993.48. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Teacher Retirement System of Texas increased its stake in shares of Hill-Rom Holdings by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 5,194 shares of the medical technology company’s stock worth $413,000 after buying an additional 14 shares during the period. Stifel Financial Corp increased its position in Hill-Rom Holdings by 0.5% during the 2nd quarter. Stifel Financial Corp now owns 4,379 shares of the medical technology company’s stock valued at $349,000 after purchasing an additional 23 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Hill-Rom Holdings by 0.5% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,734 shares of the medical technology company’s stock valued at $695,000 after purchasing an additional 46 shares during the period. Utah Retirement Systems increased its position in Hill-Rom Holdings by 0.8% during the 2nd quarter. Utah Retirement Systems now owns 12,013 shares of the medical technology company’s stock valued at $956,000 after purchasing an additional 100 shares during the period. Finally, IFP Advisors Inc increased its position in Hill-Rom Holdings by 3.0% during the 2nd quarter. IFP Advisors Inc now owns 4,607 shares of the medical technology company’s stock valued at $367,000 after purchasing an additional 135 shares during the period. 82.44% of the stock is currently owned by institutional investors.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Get a free copy of the Zacks research report on Hill-Rom Holdings (HRC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Hill-Rom Holdings (NYSE:HRC)

What are top analysts saying about Hill-Rom Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom Holdings Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit